Effects of L-arginine supplementation on exercise metabolism

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 10, Issue 1, 2007, Pages 46-51

  McConell, Glenn K ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Contraction; Endothelial function; Glucose uptake; Nitric oxide

Indexed keywords

ARGININE; NITRIC OXIDE;

CAPILLARY; CATECHOLAMINE BLOOD LEVEL; DRUG EFFECT; DRUG INFUSION; ENDOTHELIUM; EXERCISE; GLUCAGON BLOOD LEVEL; GLUCOSE TRANSPORT; GROWTH HORMONE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MUSCLE METABOLISM; PROLACTIN BLOOD LEVEL; REST; REVIEW; SKELETAL MUSCLE; SUPPLEMENTATION;

ANIMALS; ARGININE; DIETARY SUPPLEMENTS; ENDOTHELIUM; EXERCISE; HUMANS; MUSCLE, SKELETAL; NITRIC OXIDE; REST;

EID: 33845388678     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32801162fa     Document Type: Review

References (69)

1. McConell GK, Kingwell BA. Does nitric oxide regulate skeletal muscle glucose uptake during exercise? Exerc Sport Sci Rev 2006; 34:36-41. This review summarizes the evidence for and against a role of NO (and L-arginine) in the regulation of skeletal-muscle glucose uptake during exercise. There is substantial discussion of the potential reasons for the discrepant results in rodents.
2. Lau KS, Grange RW, Isotani E, et al. nNOS and eNOS modulate cGMP formation and vascular response in contracting fast-twitch skeletal muscle. Physiol Genomics 2000; 2:21-27.
3. Frandsen U, Lopez-Figueroa M, Hellsten Y. Localization of nitric oxide synthase in human skeletal muscle. Biochem Biophys Res Commun 1996; 227:88-93.
4. Lau KS, Grange RW, Chang WJ, et al. Skeletal muscle contractions stimulate cGMP formation and attenuate vascular smooth muscle myosin phosphorylation via nitric oxide. FEBS Lett 1998; 431:71-74.
5. Torres SH, De Sanctis JB, de L Briceno M, et al. Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients. J Endocrinol 2004; 181:419-427.
6. Taddei S, Virdis A, Mattei P, et al. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996; 94:1298-1303.
7. Schlaich MP, Parnell MM, Ahlers BA, et al. Impaired L-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects. Circulation 2004; 110:3680-3686.
8. Moens AL, Kass DA. Tetrahydrobiopterin and cardiovascular disease. Arterioscler Thromb Vasc Biol 2006 [E-pub ahead of print].
9. Tsikas D, Boger RH, Sandmann J, et al. Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox. FEBS Lett 2000; 478:1-3.
10. Boger RH. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor. J Nutr 2004; 134:2842S-2847S.
11. Bode-Boger SM, Boger RH, Galland A, et al. L-Arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship. Br J Clin Pharmacol 1998; 46:489-497.
12. Creager MA, Gallagher SJ, Girerd XJ, et al. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992; 90:1248-1253.
13. Maccario M, Oleandri SE, Procopio M, et al. Comparison among the effects of arginine, a nitric oxide precursor, isosorbide dinitrate and molsidomine, two nitric oxide donors, on hormonal secretions and blood pressure in man. J Endocrinol Invest 1997; 20:488-492.
14. Bode-Boger SM, Boger RH, Loffler M, et al. L-Arginine stimulates NO-dependent vasodilation in healthy humans - effect of somatostatin pretreatment. J Invest Med 1999; 47:43-50.
15. Paolisso G, Tagliamonte MR, Marfella R, et al. L-Arginine but not D-arginine stimulates insulin-mediated glucose uptake. Metabolism 1997; 46:1068-1073.
16. Apostol AT, Tayek JA. A decrease in glucose production is associated with an increase in plasma citrulline response to oral arginine in normal volunteers. Metabolism 2003; 52:1512-1516.
17. Bratusch-Marrain P, Bjorkman O, Hagenfeldt L, et al. Influence of arginine on splanchnic glucose metabolism in man. Diabetes 1979; 28:126-131.
18. Dela F, Mikines KJ, Tronier B, Galbo H. Diminished arginine-stimulated insulin secretion in trained men. J Appl Physiol 1990; 69:261-267.
19. Gannon MC, Nuttall JA, Nuttall FQ. Oral arginine does not stimulate an increase in insulin concentration but delays glucose disposal. Am J Clin Nutr 2002; 76:1016-1022.
20. Rådegran G, Saltin B. Nitric oxide in the regulation of vasomotor tone in human skeletal muscle. Am J Physiol Heart Circ Physiol 1999; 276:H1951-H1960.
21. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2:997-1000.
22. Brett SE, Cockcroft JR, Mant TG, et al. Haemodynamic effects of inhibition of nitric oxide synthase and of L-arginine at rest and during exercise. J Hypertens 1998; 16:429-435.
23. Quyyumi AA. Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine. J Am Coll Cardiol 1998; 32:904-911.
24. Bradley SJ, Kingwell BA, McConell FGK. Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans. Diabetes 1999; 48:1815-1821.
25. Hickner RC, Fisher JS, Ehsani AA, Kohrt WM. Role of nitric oxide in skeletal muscle blood flow at rest and during dynamic exercise in humans. Am J Physiol Heart Circ Physiol 1997; 273:H405-H410.
26. Roberts CK, Barnard RJ, Jasman A, Balon TW. Acute exercise increases nitric oxide synthase activity in skeletal muscle. Am J Physiol Endocrinol Metab 1999; 277:E390-E394.
27. Silveira LR, Pereira-Da-Silva L, Juel C, Hellsten Y. Formation of hydrogen peroxide and nitric oxide in rat skeletal muscle cells during contractions. Free Radic Biol Med 2003; 35:455-464.
28. Balon TW, Nadler JL. Nitric oxide release is present from incubated skeletal muscle preparations. J Appl Physiol 1994; 77:2519-2521.
29. Bode-Böger SM, Böger RH, Schroder EP, Frolich JC. Exercise increases systemic nitric oxide production in men. J Cardiovasc Risk 1994; 1:173-178.
30. McConell GK, Huynh NN, Lee-Young RS, et al. L-Arginine infusion increases glucose clearance during prolonged exercise in humans. Am J Physiol Endocrinol Metab 2006; 290:E60-E66. This is the only study conducted to date in humans that has examined the effect of L-arginine infusion on glucose uptake and liver glucose output during exercise.
31. Kingwell B, Formosa M, Muhlmann M, et al. Nitric oxide synthase inhibition reduces glucose uptake during exercise in individuals with type 2 diabetes more than in control subjects. Diabetes 2002; 51:2572-2580.
32. Kalliokoski KK, Langberg H, Ryberg AK, et al. Nitric oxide and prostaglandins influence local skeletal muscle blood flow during exercise in humans: coupling between local substrate uptake and blood flow. Am J Physiol Regul Integr Comp Physiol 2006; 291:R803-R809.
33. Higaki Y, Hirshman MF, Fujii N, Goodyear LJ. Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes 2001; 50:241-247.
34. Rottman J, Bracy D, Malabanan C, et al. Contrasting effects of exercise and NOS inhibition on tissue-specific fatty acid and glucose uptake in mice. Am J Physiol Endocrinol Metab 2002; 283:E116-E123.
35. Balon TW, Nadler JL. Evidence that nitric oxide increases glucose transport in skeletal muscle. J Appl Physiol 1997; 82:359-363.
36. Roberts CK, Barnard RJ, Scheck SH, Balon TW. Exercise-stimulated glucose transport in skeletal muscle is nitric oxide dependent. Am J Physiol Endocrinol Metab 1997; 273:E220-E225.
37. Stephens TJ, Canny BJ, Snow RJ, McConell GK. 5′-Aminoimidazole-4- carboxyamide-ribonucleoside-activated glucose transport is not prevented by nitric oxide synthase inhibition in rat isolated skeletal muscle. Clin Exp Pharmacol Physiol 2004; 31:419-423.
38. Wheatley CM, Rattigan S, Richards SM, et al. Skeletal muscle contraction stimulates capillary recruitment and glucose uptake in insulin-resistant obese Zucker rats. Am J Physiol Endocrinol Metab 2004; 287:E804-E809.
39. Vincent MA, Barrett EJ, Lindner JR, et al. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab 2003; 285:E123-E129.
40. Jenkins AB, Chisholm DJ, James DE, et al. Exercise-induced hepatic glucose output is precisely sensitive to the rate of systemic glucose supply. Metabolism 1985; 34:431-436.
41. Ming Z, Han C, Lautt WW. Nitric oxide inhibits norepinephrine-induced hepatic vascular responses but potentiates hepatic glucose output. Can J Physiol Pharmacol 2000; 78:36-44.
42. McConell G, Fabris S, Proietto J, Hargreaves M. Effect of carbohydrate ingestion on glucose kinetics during exercise. J Appl Physiol 1994; 77:1537-1541.
43. Klatt P, Cacho J, Crespo MD, et al. Nitric oxide inhibits isoproterenol-stimulated adipocyte lipolysis through oxidative inactivation of the beta-agonist. Biochem J 2000; 351:485-493.
44. Gaudiot N, Jaubert AM, Charbonnier E, et al. Modulation of white adipose tissue lipolysis by nitric oxide. J Biol Chem 1998; 273:13475-13481.
45. Andersson K, Gaudiot N, Ribiere C, et al. A nitric oxide-mediated mechanism regulates lipolysis in human adipose tissue in vivo. Br J Pharmacol 1999; 126:1639-1645.
46. Kanaya Y, Nakamura M, Kobayashi N, Hiramori K. Effects of L-arginine on lower limb vasodilator reserve and exercise capacity in patients with chronic heart failure. Heart 1999; 81:512-517.
47. Wennmalm A, Edlund A, Granstrom EF, Wiklund O. Acute supplementation with the nitric oxide precursor L-arginine does not improve cardiovascular performance in patients with hypercholesterolemia. Atherosclerosis 1995; 118:223-231.
48. Eto B, Peres G, Le Moel G. Effects of an ingested glutamate arginine salt on ammonemia during and after long lasting cycling. Arch Int Physiol Biochim Biophys 1994; 102:161-162.
49. Schaefer A, Piquard F, Geny B, et al. L-Arginine reduces exercise-induced increase in plasma lactate and ammonia. Int J Sports Med 2002; 23:403-407.
50. Palloshi A, Fragasso G, Piatti P, et al. Effect of oral L-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteries. Am J Cardiol 2004; 93:933-935.
51. Piatti PM, Monti LD, Valsecchi G, et al. Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care 2001; 24:875-880.
52. Lucotti PC, Setola E, Monti LD, et al. Beneficial effects of oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin resistant type 2 diabetic patients. Am J Physiol Endocrinol Metab 2006; 291:E906-E912. This is an important study which demonstrates that L-arginine interacts with exercise training and a hypocaloric diet to improve insulin sensitivity in people with type 2 diabetes.
53. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002; 51:2944-2950.
54. Nisoli E, Falcone S, Tonello C, et al. Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc Natl Acad Sci U S A 2004; 101:16507-16512.
55. Wadley GD, McConell GK. Effect of nitric oxide synthase inhibition on mitochondrial biogenesis in rat skeletal muscle. J Appl Physiol 2006 [E-pub ahead of print].
56. Napoli C, Williams-Ignarro S, de Nigris F, et al. Physical training and metabolic supplementation reduce spontaneous atherosclerotic plaque rupture and prolong survival in hypercholesterolemic mice. Proc Natl Acad Sci U S A 2006; 103:10479-10484.
57. Suzuki J. L-Arginine supplementation causes additional effects on exercise-induced angiogenesis and VEGF expression in the heart and hind-leg muscles of middle-aged rats. J Physiol Sci 2006; 56:39-44.
58. Gavin TP, Spector DA, Wagner H, et al. Nitric oxide synthase inhibition attenuates the skeletal muscle VEGF mRNA response to exercise. J Appl Physiol 2000; 88:1192-1198.
59. Maxwell AJ, Ho HV, Le CQ, et al. L-Arginine enhances aerobic exercise capacity in association with augmented nitric oxide production. J Appl Physiol 2001; 90:933-938.
60. Walker HA, McGing E, Fisher I, et al. Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance. J Am Coll Cardiol 2001; 38:499-505.
61. Ceremuzynski L, Chamiec T, Herbaczynska-Cedro K. Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris. Am J Cardiol 1997; 80:331-333.
62. Rector TS, Bank AJ, Mullen KA, et al. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation 1996; 93:2135-2141.
63. Cheng JW, Baldwin SN. L-Arginine in the management of cardiovascular diseases. Ann Pharmacother 2001; 35:755-764.
64. Nagaya N, Uematsu M, Oya H, et al. Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension. Am J Respir Crit Care Med 2001; 163:887-891.
65. Doutreleau S, Mettauer B, Piquard F, et al. Chronic L-arginine supplementation enhances endurance exercise tolerance in heart failure patients. Int J Sports Med 2006; 27:567-572.
66. Denis C, Dormois D, Linossier MT, et al. Effect of arginine aspartate on the exercise-induced hyperammoniemia in humans: a two periods cross-over trial. Arch Int Physiol Biochim Biophys 1991; 99:123-127.
67. Colombani PC, Bitzi R, Frey-Rindova P, et al. Chronic arginine aspartate supplementation in runners reduces total plasma amino acid level at rest and during a marathon run. Eur J Nutr 1999; 38:263-270.
68. Campbell B, Roberts M, Kerksick C, et al. Pharmacokinetics, safety, and effects on exercise performance of L-arginine alpha-ketoglutarate in trained adult men. Nutrition 2006; 22:872-881.
69. Abel T, Knechtle B, Perret C, et al. Influence of chronic supplementation of arginine aspartate in endurance athletes on performance and substrate metabolism - a randomized, double-blind, placebo-controlled study. Int J Sports Med 2005; 26:344-349.